Cao Jian, Liu Jun, Xu Ran, Zhu Xuan, Zhao Xiaokun, Qian Bin-Zhi
Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
MRC Centre for Reproductive Health, Queen's Medical Research Institute, Edinburgh EH16 4TJ, United Kingdom.
Oncotarget. 2017 Jun 27;8(47):83261-83269. doi: 10.18632/oncotarget.18743. eCollection 2017 Oct 10.
Recent studies suggested that the tumour associated macrophages may be associated with prostate cancer outcome. A meta-analysis was performed to evaluate the prognostic value of tumor associated macrophages and macrophage scavenger receptor 1, marker for a subset of macrophages, by pooled hazard ratio and 95% confidence intervals from qualified studies following a systemic search. The results indicate that higher infiltration of tumor associated macrophages predicts poor overall survival (HR=1.57, 95%CI: 1.15-1.98), but not biochemical recurrence (HR=1.01, 95%CI: 0.98-1.04) or recurrence-free survival (HR=1.03, 95%CI: 0.05-2.01). In contrast, elevated level of macrophage scavenger receptor 1 was significantly associated with better recurrence-free survival (HR=3.26, 95%CI: 1.22-5.29). Thus, our analysis confirmed the prognostic value of these markers in prostate cancer outcome. We also discussed potential causes of the controversies in the literature and future research directions.
近期研究表明,肿瘤相关巨噬细胞可能与前列腺癌的预后相关。我们进行了一项荟萃分析,通过系统检索合格研究中的合并风险比和95%置信区间,评估肿瘤相关巨噬细胞及巨噬细胞清道夫受体1(一种巨噬细胞亚群的标志物)的预后价值。结果表明,肿瘤相关巨噬细胞浸润程度较高预示着总体生存率较差(HR=1.57,95%CI:1.15-1.98),但与生化复发(HR=1.01,95%CI:0.98-1.04)或无复发生存率无关(HR=1.03,95%CI:0.05-2.01)。相反,巨噬细胞清道夫受体1水平升高与更好的无复发生存率显著相关(HR=3.26,95%CI:1.22-5.29)。因此,我们的分析证实了这些标志物在前列腺癌预后中的价值。我们还讨论了文献中争议的潜在原因及未来的研究方向。